The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells

被引：0
|
作者：
James W Welsh
Daruka Mahadevan
Ron Ellsworth
Laurence Cooke
David Bearss
Baldassarre Stea
机构：
[1] The University of Texas M. D. Anderson Cancer Center,Departmentr of Radiation Oncology
[2] University of Arizona Cancer Center,Department of Medicine
[3] University of Arizona College of Medicine,Department of Radiation Oncology
[4] SuperGen Inc,undefined
[5] University of Arizona Cancer Center,undefined
来源：
Radiation Oncology | / 4卷
关键词：
Hepatocyte Growth Factor; Comet Assay; SF767 Cell; RAD51 Expression; Neutral Comet Assay;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
    Welsh, James W.
    Mahadevan, Daruka
    Ellsworth, Ron
    Cooke, Laurence
    Bearss, David
    Stea, Baldassarre
    RADIATION ONCOLOGY, 2009, 4
  • [2] The radiosensitizing effects of a novel tyrosine kinase inhibitor, Mp470 in glioblastoma Multiforme stem cells
    Ellsworth, R.
    Welsh, J.
    Mahadevan, D.
    Bearrs, D.
    Hsieh, D.
    Fjerstad, K.
    Marsella, M.
    Sanan, A.
    Badrudojja, M.
    Stea, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S714 - S715
  • [3] Sensitization of a glioblastoma multiforme (GBM) cell line by MP470: A novel c-met antagonist
    Welsh, J.
    Mahadevan, D.
    Bearss, D.
    Stea, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S100 - S100
  • [4] MP470, a small molecule tyrosine kinase inhibitor, induces apoptosis in multiple myeloma cells
    Phillip, Cornel
    Balakrishnan, Kumudha
    Stellrecht, Christine
    Gandhi, Varsha
    CANCER RESEARCH, 2009, 69
  • [5] The novel multi-targeted receptor tyrosine kinase inhibitor MP470 inhibits synovial sarcoma proliferation in vitro
    Combs, D.
    Craniner, L. D.
    Trevor, K. T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 224 - 225
  • [6] The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination
    Zhao, Helen
    Luoto, Kaisa R.
    Meng, Alice X.
    Bristow, Robert G.
    RADIOTHERAPY AND ONCOLOGY, 2011, 101 (01) : 59 - 65
  • [7] A selective inhibitor targeting c-Met receptor tyrosine kinase in gastric cancer
    Park, Byung Hee
    Yun, Sun-Mi
    Jung, Kyung Hee
    Lee, Hyunseung
    Hong, Soon-Sun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 350 - 350
  • [8] Nuclear receptor tyrosine kinase c-MET restrains efficacy of PARP inhibitor in pancreatic cancer cells
    Gao, Yuan
    Chen, Mei-Kuang
    Yu, Dihua
    Hung, Mien-Chie
    CANCER RESEARCH, 2020, 80 (16)
  • [9] In vivo imaging of c-Met receptor tyrosine kinase using c-Met binding peptide
    Kim, Eun-Mi
    Park, Eun-Hye
    Lee, Chang-Moon
    Cheong, Su-Jin
    Kim, Dong-Wook
    Lim, Seok Tae
    Sohn, Myung-Hee
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [10] TYROSINE KINASE RECEPTOR INDISTINGUISHABLE FROM THE C-MET PROTEIN
    GIORDANO, S
    PONZETTO, C
    DIRENZO, MF
    COOPER, CS
    COMOGLIO, PM
    NATURE, 1989, 339 (6220) : 155 - 156
12345